Swedbank AB Has $68.72 Million Stake in STERIS plc $STE

Swedbank AB raised its stake in shares of STERIS plc (NYSE:STE) by 5.7% in the 4th quarter, Holdings Channel reports. The firm owned 271,078 shares of the medical equipment provider’s stock after purchasing an additional 14,500 shares during the quarter. Swedbank AB’s holdings in STERIS were worth $68,724,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the stock. Vanguard Group Inc. raised its position in STERIS by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 12,286,535 shares of the medical equipment provider’s stock worth $3,114,882,000 after purchasing an additional 73,014 shares during the last quarter. State Street Corp raised its position in STERIS by 4.0% during the 3rd quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider’s stock worth $1,077,564,000 after purchasing an additional 166,736 shares during the last quarter. Orbis Allan Gray Ltd raised its position in STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after purchasing an additional 556,088 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in STERIS by 16.4% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider’s stock worth $387,797,000 after purchasing an additional 221,199 shares during the last quarter. Finally, Invesco Ltd. raised its position in STERIS by 4.9% during the 3rd quarter. Invesco Ltd. now owns 1,280,142 shares of the medical equipment provider’s stock worth $316,758,000 after purchasing an additional 59,443 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

Insider Buying and Selling at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the transaction, the director directly owned 705 shares of the company’s stock, valued at approximately $167,233.05. This trade represents a 81.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.07% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on STE shares. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 16th. Weiss Ratings lowered STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Thursday, April 16th. KeyCorp lowered their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $270.00 target price on shares of STERIS in a research report on Thursday. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $274.25.

STERIS Stock Performance

STE stock opened at $216.69 on Friday. The stock has a 50-day moving average price of $218.41 and a 200-day moving average price of $242.13. STERIS plc has a 1-year low of $195.14 and a 1-year high of $269.44. The company has a current ratio of 2.09, a quick ratio of 1.54 and a debt-to-equity ratio of 0.25. The firm has a market cap of $21.25 billion, a PE ratio of 27.32 and a beta of 0.95.

STERIS (NYSE:STE) last posted its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing the consensus estimate of $2.86 by ($0.03). STERIS had a return on equity of 14.15% and a net margin of 13.18%.The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $2.74 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, equities research analysts expect that STERIS plc will post 11.18 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 8th will be given a $0.63 dividend. The ex-dividend date of this dividend is Monday, June 8th. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. STERIS’s dividend payout ratio (DPR) is 31.78%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.